MetaCap

Adaptive Biotechnologies Statistics

NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

27.93-0.12 (-0.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Adaptive Biotechnologies by the numbers

Adaptive Biotechnologies has a market capitalization of $4.52 billion based on 161.88M shares outstanding. With trailing EPS of $-0.45, Adaptive Biotechnologies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.3% above its 50-day average and 37.3% above its 200-day average.

Average daily trading volume is 2.20M shares, or about $61.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ADPT valuation vs. peer median

ADPT compared with the median of 8 peer companies
MetricADPTPeer medianDifference
Market cap$4.52B$3.38B+34%
Avg. volume2.20M1.80M+22%

Peer median across 8 companies: CRSP, TARS, RLAY, SRRK, IOVA, DNLI, VCEL, ADMA.

Valuation

Price / sales (latest FY)
16.32
EPS (TTM)
$-0.45

Price and trading

Previous close
28.05
Open
27.43
Day range
27.15 – 28.23
52-week range
12.00 – 32.21
52-week change
+50.08%
Beta
—
Volume
2.48M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
4.52B
Forward Pe
-837.98
Eps
-0.45
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
32.21
Week52 Low
12.00
Avg Volume
2.20M
Shares Outstanding
161.88M
Ma50
27.29
Ma200
20.35
Earnings Date
Nov 4, 2026
Pct From52w High
-13.29%
Pct From52w Low
132.75%

Related